Legal status · Canada
Is Neurotensin legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Neurotensin is not an approved medicine in Canada; its classification is "Not a medicine; endogenous signalling molecule". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Neurotensin in Canada at a glance
| Classification | Not a medicine; endogenous signalling molecule |
|---|---|
| Note | Not a drug product. No authorised agonist at this receptor. |
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 2 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Neurotensin profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing Neurotensin is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What Neurotensin is
An endogenous 13 residue peptide with rodent analgesia data and no human trial of any cognitive or pain endpoint. The human infusion studies that do exist measured gut motility: intravenous neurotensin increased colonic contraction duration to 76% in the ascending colon, and patients discharged a median 600 mL of bowel contents 20 minutes after the infusion stopped.
Neurotensin is an endogenous 13 residue peptide, annotated in UniProt P30990 at residues 151 to 163, cleaved from a precursor that also yields neuromedin N. It is a real and well-studied neuropeptide in animal neuroscience, with roles proposed in analgesia, thermoregulation, blood pressure and the pathophysiology of schizophrenia.
Mechanism: Proposed for the uses it is sold for, demonstrated for the ones it is not. Neurotensin acts at NTSR1 and NTSR2, G protein-coupled receptors, and at the sortilin-related NTSR3.
Regulatory history: Neurotensin is an endogenous peptide and is not a medicine. No neurotensin product or neurotensin receptor agonist is approved in any jurisdiction, and no interventional trial of either for pain is registered.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Neurotensin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Neurotensin in other countries
United States
Not approvedNot a medicine; endogenous signalling molecule
Is Neurotensin legal in the United States?United Kingdom
Not approvedNot a medicine; endogenous signalling molecule
Is Neurotensin legal in the United Kingdom?Australia
Not approvedNot a medicine; endogenous signalling molecule
Is Neurotensin legal in Australia?Frequently asked questions
Is Neurotensin legal in Canada?
No. Neurotensin is not an approved medicine in Canada; its classification is "Not a medicine; endogenous signalling molecule". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile. Note: Not a drug product. No authorised agonist at this receptor.
Can I buy Neurotensin in Canada?
No approved product exists to buy. In Canada Neurotensin is classified as "Not a medicine; endogenous signalling molecule", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Not a drug product. No authorised agonist at this receptor.
Is Neurotensin Health Canada approved?
No. In Canada Neurotensin is classified as "Not a medicine; endogenous signalling molecule", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Neurotensin is an endogenous peptide and is not a medicine. No neurotensin product or neurotensin receptor agonist is approved in any jurisdiction, and no interventional trial of either for pain is registered.. On the evidence, 2 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Neurotensin live on its compound profile.
Neurotensin profileThis page is general information about the regulatory status of Neurotensin in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.